Biobanking for epidemiological research and public health

Angela M. Brand, Nicole M. Probst-Hensch

Research output: Contribution to journalReview article

25 Citations (Scopus)

Abstract

Almost all healthcare systems are currently facing fundamental challenges. New ways of organizing these systems based on novel knowledge and stakeholders' different needs are required to meet these challenges at the appropriate time. In this context, the issue of biobanking has become a specific challenge having major implications for future research and policy strategies as well as for the healthcare systems in general. Medicine is currently undergoing remarkable developments from its morphological and phenotype orientation to a molecular and genotype orientation, promoting the importance of prognosis and prediction. Yet, the discussion about the relevance of integrating genome-based information into biobanks and about the role of genome-based biobanking for epidemiological research and public health is still at the beginning. The following article contributes to this discussion by focusing on the use of genome-based biobanking for epidemiological research, surveillance systems, health policy development, individual health information management and effective health services.

Original languageEnglish
Pages (from-to)227-238
Number of pages12
JournalPathobiology
Volume74
Issue number4
DOIs
Publication statusPublished - 08-2007

Fingerprint

Public Health
Genome
Health Information Management
Research
Delivery of Health Care
Policy Making
Health Policy
Health Services
Genotype
Medicine
Phenotype

All Science Journal Classification (ASJC) codes

  • Pathology and Forensic Medicine
  • Molecular Biology
  • Cell Biology

Cite this

Brand, Angela M. ; Probst-Hensch, Nicole M. / Biobanking for epidemiological research and public health. In: Pathobiology. 2007 ; Vol. 74, No. 4. pp. 227-238.
@article{846ae19dd4364c10958191a3e0fd8396,
title = "Biobanking for epidemiological research and public health",
abstract = "Almost all healthcare systems are currently facing fundamental challenges. New ways of organizing these systems based on novel knowledge and stakeholders' different needs are required to meet these challenges at the appropriate time. In this context, the issue of biobanking has become a specific challenge having major implications for future research and policy strategies as well as for the healthcare systems in general. Medicine is currently undergoing remarkable developments from its morphological and phenotype orientation to a molecular and genotype orientation, promoting the importance of prognosis and prediction. Yet, the discussion about the relevance of integrating genome-based information into biobanks and about the role of genome-based biobanking for epidemiological research and public health is still at the beginning. The following article contributes to this discussion by focusing on the use of genome-based biobanking for epidemiological research, surveillance systems, health policy development, individual health information management and effective health services.",
author = "Brand, {Angela M.} and Probst-Hensch, {Nicole M.}",
year = "2007",
month = "8",
doi = "10.1159/000104450",
language = "English",
volume = "74",
pages = "227--238",
journal = "Pathobiology",
issn = "1015-2008",
publisher = "S. Karger AG",
number = "4",

}

Biobanking for epidemiological research and public health. / Brand, Angela M.; Probst-Hensch, Nicole M.

In: Pathobiology, Vol. 74, No. 4, 08.2007, p. 227-238.

Research output: Contribution to journalReview article

TY - JOUR

T1 - Biobanking for epidemiological research and public health

AU - Brand, Angela M.

AU - Probst-Hensch, Nicole M.

PY - 2007/8

Y1 - 2007/8

N2 - Almost all healthcare systems are currently facing fundamental challenges. New ways of organizing these systems based on novel knowledge and stakeholders' different needs are required to meet these challenges at the appropriate time. In this context, the issue of biobanking has become a specific challenge having major implications for future research and policy strategies as well as for the healthcare systems in general. Medicine is currently undergoing remarkable developments from its morphological and phenotype orientation to a molecular and genotype orientation, promoting the importance of prognosis and prediction. Yet, the discussion about the relevance of integrating genome-based information into biobanks and about the role of genome-based biobanking for epidemiological research and public health is still at the beginning. The following article contributes to this discussion by focusing on the use of genome-based biobanking for epidemiological research, surveillance systems, health policy development, individual health information management and effective health services.

AB - Almost all healthcare systems are currently facing fundamental challenges. New ways of organizing these systems based on novel knowledge and stakeholders' different needs are required to meet these challenges at the appropriate time. In this context, the issue of biobanking has become a specific challenge having major implications for future research and policy strategies as well as for the healthcare systems in general. Medicine is currently undergoing remarkable developments from its morphological and phenotype orientation to a molecular and genotype orientation, promoting the importance of prognosis and prediction. Yet, the discussion about the relevance of integrating genome-based information into biobanks and about the role of genome-based biobanking for epidemiological research and public health is still at the beginning. The following article contributes to this discussion by focusing on the use of genome-based biobanking for epidemiological research, surveillance systems, health policy development, individual health information management and effective health services.

UR - http://www.scopus.com/inward/record.url?scp=34548082017&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=34548082017&partnerID=8YFLogxK

U2 - 10.1159/000104450

DO - 10.1159/000104450

M3 - Review article

VL - 74

SP - 227

EP - 238

JO - Pathobiology

JF - Pathobiology

SN - 1015-2008

IS - 4

ER -